Calponin与MUC6补充抑制素作为EUS-FNAB标本中浆液性囊腺瘤的诊断免疫标志物
本研究比较了四种潜在浆液性囊腺瘤(SCA)免疫标志物(calponin、MUC6、GLUT1、VEGFA)与抑制素在EUS-FNAB标本中的诊断价值,并与神经内分泌肿瘤(NET)对比。结果显示MUC6胞质表达对SCA的敏感性和特异性均为100%,calponin敏感性低于抑制素(71% vs 100%)但特异性更高(100% vs 91%),且比MUC6更易评估。结论认为calponin和MUC6是抑制素的有用补充标志物。
要点
- MUC6胞质表达对SCA的敏感性和特异性均为100%,但需注意胰腺、胃、十二指肠生理性表达干扰。
- Calponin敏感性71%、特异性100%,较抑制素更特异且比MUC6易评估。
- GLUT1和VEGFA不适用于SCA诊断,NET表达率分别为10%和44%。
核心结论
- 在文献提示的四种SCA潜在免疫标志物中,calponin和MUC6是抑制素的有用补充检查,适用于EUS-FNAB标本。
研究设计与样本
- 对30例SCA的EUS-FNAB标本和3例SCA切除标本以及32例NET的EUS-FNAB标本进行calponin、MUC6、GLUT1和VEGFA免疫组化检测。
主要发现
- GLUT1和VEGFA作为SCA诊断标志物不理想,NET表达率分别为10%和44%。
- 19%的NET显示MUC6核阳性,但MUC6胞质表达作为SCA标志物的敏感性和特异性均为100%。
- Calponin敏感性低于抑制素(71% vs 100%),但特异性更高(100% vs 91%),且比MUC6更易在EUS-FNAB标本中评估。
关键数值与推荐
- MUC6胞质表达对SCA的敏感性和特异性均为100%。
- Calponin对SCA的敏感性为71%,特异性为100%;抑制素敏感性100%,特异性91%。
- GLUT1和VEGFA在NET中的表达率分别为10%和44%。
临床怎么用
- 在EUS-FNAB标本中评估SCA时,calponin和MUC6可作为抑制素的补充免疫标志物。
- 评估MUC6时需警惕胰腺、胃或十二指肠生理性组织的局灶表达造成的假阳性。
- GLUT1和VEGFA因NET表达及血细胞污染干扰,不推荐用于SCA诊断。
局限性
- MUC6在EUS-FNAB标本中评估需考虑生理性胰腺、胃或十二指肠组织的局灶表达污染。
- GLUT1和VEGFA因血细胞污染妨碍肿瘤细胞识别,尤其在细胞贫乏样本中。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Because serous cystadenoma (SCA) does not usually require excision, it is critical to distinguish it from differential diagnoses which do, especially neuroendocrine tumour (NET). The gold standard for diagnosing SCA is assessment of endoscopic ultrasound-guided fine needle aspiration/biopsy (EUS-FNAB) material. Inhibin immunohistochemistry aids this assessment, but such positivity is not absolutely sensitive or specific to SCA. The following is the largest known study of SCA EUS-FNAB specimens and the first to compare four potential SCA immunomarkers between themselves and inhibin, compared against NET. METHODS AND RESULTS: Immunohistochemistry for calponin, mucin 6 (MUC6), glucose transporter 1 (GLUT1) and vascular endothelial growth factor A (VEGFA) was performed on 30 EUS-FNAB and three resection specimens of SCA and 32 EUS-FNAB specimens of NET. GLUT1 and VEGFA were suboptimal as diagnostic immunomarkers of SCA, being expressed by 10 and 44% of NETs, respectively. Further, their expression by cellular constituents of blood which often contaminate EUS-FNAB specimens hampered identification of neoplastic cells, especially in hypocellular samples. While 19% of NETs showed nuclear MUC6 positivity, cytoplasmic expression of the protein showed 100% specificity and sensitivity as an SCA marker. However, assessing MUC6 in EUS-FNAB specimens must also consider the protein's focal expression in physiological pancreatic, gastric or duodenal tissues, which can contaminate these specimens. Calponin was less sensitive (71% versus 100%) but more specific (100% versus 91%) than inhibin, although easier to assess in EUS-FNAB specimens than MUC6. CONCLUSIONS: Of the four potential immunomarkers of SCA suggested by the existing literature, calponin and MUC6 are useful complementary studies to inhibin for application to EUS-FNAB specimens.
引用
- Wong NACS, Beavers S, Gill P, et al. Calponin and MUC6 complement inhibin as diagnostic immunomarkers of serous cystadenoma in endoscopic ultrasound-guided aspiration/biopsy specimens. Histopathology. 2021. PMID: 33657658. doi:10.1111/his.14362
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。